Emulsi Biotech AB
1 known investors
Emulsi develops NanoLIPID™, a natural lipid technology that self-assembles into nano-structures for encapsulating active pharmaceutical ingredients, nutraceuticals, and bioactive compounds. The platform targets oral drug delivery, cosmetics, and nutraceutical applications.
Investors · 1
Frequently asked questions
- What does Emulsi Biotech AB do?
- Emulsi develops NanoLIPID™, a natural lipid technology that self-assembles into nano-structures for encapsulating active pharmaceutical ingredients, nutraceuticals, and bioactive compounds. The platform targets oral drug delivery, cosmetics, and nutraceutical applications.
- Who are Emulsi Biotech AB's investors?
- Emulsi Biotech AB's investors include BSV Ventures.